CXCL10 and ductal breast carcinoma in situ: In a previous study which evaluated expression of CXCL10 in 6 cases of breast cancer (comprised of 3 cases of DCIS and 3 cases of invasive carcinoma) compared to normal breast using immunohistochemistry, invasive carcinoma showed markedly increased expression of CXCL10.